O36.111
Maternal care for Anti-A sensitization, first trimester
Clinical Classification Guidelines
Medical Intelligence & Overview
Maternal care for Anti-A sensitization during the first trimester involves monitoring and managing a mother's immune response to the anti-A antibodies, which can affect the fetus. This condition is part of the broader category of maternal-fetal blood group incompatibility, specifically related to the A blood group antigen. Proper care is crucial to prevent complications and ensure the health and safety of both mother and baby during early pregnancy.
Causes & Symptoms
Clinical Causes: Mother's blood type is A, and she is sensitized to Anti-A antibodies Prior pregnancies or blood transfusions that introduced the A antigen into the mother's bloodstream Presence of Anti-A antibodies in the mother's blood due to immune response Lack of previous exposure or immune sensitization prior to current pregnancy
Key Symptoms: Typically asymptomatic during early pregnancy Potential for signs related to immune response, though rare in initial sensitization No specific symptoms directly attributable to Anti-A sensitization
Diagnostic & Treatment
Diagnosis Path: Diagnosis of Anti-A sensitization begins with blood tests to determine maternal blood type and antibody presence. During pregnancy, antibody titers are monitored to assess the risk of fetal involvement. Ultrasound evaluations may be used to check for signs of fetal anemia or other complications. In some cases, amniocentesis or fetal blood sampling might be considered to evaluate the fetus’s condition if necessary.
Treatment Protocols: Management focuses on monitoring and preventing adverse fetal outcomes. This includes regular antibody titer testing to track immune response levels. If antibody levels increase, additional diagnostics like fetal blood flow assessment may be performed. In rare cases, interventions such as intrauterine transfusions might be needed if fetal anemia develops. Postnatal care may involve neonatal testing and management if incompatibility has caused issues.
Clinical Advice & FAQs
Billing Guidance
Is O36.111 a billable ICD-10 code?
Yes, O36.111 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report O36.111?
Clinical documentation must specify the nature of Maternal care for Anti-A sensitization, first trimester and any associated comorbidities for accurate reporting.
Cite this Clinical Reference